Clinical trials for lung cancer
130 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial

Phase 1 / Phase 2
Lung cancer
#NCT06448572
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
1
2
3 or more
ALK
BRAF
EGFR
HER2
MET
RET
ROS-1
Centre Hospitalier Universitaire de Lille (Lille)
CHU Lille
Phase 1 / Phase 2
Lung cancer
#NCT05650879
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
HER2
Chemotherapy
1
2
3 or more
ALK
BRAF
EGFR
ROS-1
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Centre Léon Bérard (Lyon), Hôpital de la Timone AP-HM (Marseille), Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ) (and 1 more...)
Enliven Therapeutics
Phase 1 / Phase 2
Lung cancer
#NCT05592626
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
MSI/dMMR
1
2
3 or more
Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux)
Marengo Therapeutics, Inc.
Phase 1 / Phase 2
Lung cancer
#NCT05469178
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
None
ALK
BRAF
EGFR
MET
NTRK-1/2/3
RET
ROS-1
Chemotherapy
Hôpital Privé du Confluent - Vivalto Santé (Nantes), Centre Antoine Lacassagne (Nice), Gustave Roussy (Villejuif), Hôpital Européen Georges Pompidou - AP-HP (Paris)
BerGenBio ASA
Phase 1 / Phase 2
Lung cancer
#NCT04626635
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Immunotherapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpital d'instruction des Armées Bégin (Saint-Mandé), Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon) (and 5 more...)
Regeneron Pharmaceuticals
Phase 1 / Phase 2
Lung cancer
#NCT04626635
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Systemic Treatment-Naive
Immunotherapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpital d'instruction des Armées Bégin (Saint-Mandé), Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon) (and 5 more...)
Regeneron Pharmaceuticals
Phase 1 / Phase 2
Lung cancer
#NCT04143711
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
HER2
Immunotherapy
Chemotherapy
1
2
3 or more
Systemic Treatment-Naive
Institut du cancer de Montpellier (Montpellier), CHU de Rennes - Hôpital Pontchaillou (Rennes), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Hôpital Pitié Salpêtrière - AP-HP (Paris), Groupe Hospitalier Saint André (Bordeaux) (and 6 more...)
Dragonfly Therapeutics
Phase 1 / Phase 2
Lung cancer
#NCT04104776
SCLC (Small Cell Lung Cancer)
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ARID1A
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes) (and 2 more...)
Constellation Pharmaceutique
Phase 1 / Phase 2
Lung cancer
#NCT04104776
Mesothelium
Locally Advanced
Metastatic
Other mutation
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes) (and 2 more...)
Constellation Pharmaceutique
Phase 1 / Phase 2
#NCT05544552
Locally Advanced
Metastatic
FGFR
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), IUCT Oncopôle (Toulouse), Gustave Roussy (Villejuif)
Tyra Biosciences, Inc